Bioscience firms from Huntsville to Mobile are represented in an Alabama trade delegation which has spent this week in the United Kingdom and Ireland.
Today, the team was at the Babraham Institute in Cambridge. That stop will be followed by a visit to the Cambridge Biomedical Campus and One Nucleus, an organization focusing on life sciences and health care.
Among the firms taking part are:
Huntsville’s Hudson Alpha Institute of Biotechnology, the genomics research center.
Birmingham’s AerBetic Inc., which is developing a wearable diabetes alert device.
ADT Pharmaceuticals and PDEi Pharmaceuticals, with new treatments for erectile dysfunction and pulmonary arterial hypertension.
BioGX of Birmingham, which develops and manufactures molecular biology reagents.
Cytoviva Inc. of Auburn, which provides enhanced darkfield optical microscopy and hyperspectral imaging technology.
GeneCapture of Huntsville, developers of a rapid infection detection instrument to screen a human sample for 200 pathogens in less than an hour.
Swift Biotechnology, which is working on an early stage, proteomic-based test for ovarian cancer based on technology from USA’s Mitchell Cancer Institute.
Synvivo Inc. of Huntsville, with 3D tissue-organ on chip models that facilitate real-time study of cell and drug interactions.
TriAltus Bioscience of Birmingham, with tools for the expression and purification of genetically engineered proteins.
BioAlabama, the state’s bioscience trade group. According to an analysis for BioAlabama, the state’s biosciences industry generates $7.3 billion in economic activity annually, with 780 companies and nearly 48,000 direct and indirect jobs.
Hilda Lockhart, director of the International Trade Office at the Alabama Department of Commerce, said international cooperation can be a driver for momentum in biosciences.